SARS-CoV2 infection as a potential trigger for severe relapse in a patient with multiple sclerosis who stopped disease modifying treatment due to COVID-19 pandemic

BACKGROUND: During COVID-19 pandemic safety of disease modifying treatments (DMT) in patients with multiple sclerosis (MS) is still under debate. While there is no clear evidence for a higher risk of severe SARS-CoV-2 infection under DMT the risk of rebound of disease activity in case of stopping DM...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Neuroimmunology Reports
Autori principali: Auer, Michael, Berek, Klaus, Fava, Elena, Zinganell, Anne, Deisenhammer, Florian, Hegen, Harald, Di Pauli, Franziska
Natura: Artigo
Lingua:Inglês
Pubblicazione: The Author(s). Published by Elsevier B.V. 2021
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC8285927/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.nerep.2021.100005
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi